The Motley Fool Discussion Boards
Investing/Strategies / Biotech and The Gorilla Game
|Subject: Gorillas elsewhere on TMF & Intronn||Date: 11/13/2003 6:48 PM|
|Author: Hallucigenia||Number: 67 of 70|
Thought I'd do this board's post for 2003 by pointing out a cracking discussion of gorilla tactics elsewhere on the Fool :
I'm not a great believer that biology is a good arena for gorilla gaming, but I thought I might put in a shout for a private company, Intronn, which has some rather neat technology for 'editing' mRNAs using spliceosomes. Which is neat, they can replace mutant RNAs with the 'correct' one using just a few hundred bp rather than a full gene of several kb's, which means they can deliver using chemistry rather than viruses. And they can also insert a toxin gene into the mRNA, or something that allows them to image cells that are expressing a particular gene. It's very cute science, even if they're only proven it to work in animal models so far. Their key patent on transplicing is US 6,013,487.
Disclaimer : I hold shares in Proteome Sciences (PRM.L), who funded Intronn as a startup and retain 30.87% of the equity. I'll be doing a more detailed post on the current state of play at Intronn within the next few days over on the PRM.L board :
|Copyright 1996-2016 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us|